BioHealth Capital RegionIndustry TrendsResearch Aldevron and Minaris Renew Lentiviral Plasmid Agreement to Accelerate Cell and Gene Therapy Development May 12, 2026
BioHealth Capital RegionFundingIndustry Trends Private Equity’s Next Bet in Cell and Gene Therapy Manufacturing, Rose BioSolutions May 11, 2026
Greater PhiladelphiaIndustry Trends Minaris Hits 100% Batch Success on Chimeric’s CDH17 CAR-T Program as Autologous Manufacturing Enters a More Disciplined Era April 23, 2026